AAAAAA
Results:
1-7
|
Results: 7
Authors:
Sievers, EL
Larson, RA
Stadtmauer, EA
Estey, E
Lowenberg, B
Dombret, H
Karanes, C
Theobald, M
Bennett, JM
Sherman, ML
Berger, MS
Eten, CB
Loken, MR
van Dongen, JJM
Bernstein, ID
Appelbaum, FR
Citation: El. Sievers et al., Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse, J CL ONCOL, 19(13), 2001, pp. 3244-3254
Authors:
Zang, DY
Goodwin, RG
Loken, MR
Bryant, E
Deeg, HJ
Citation: Dy. Zang et al., Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis, BLOOD, 98(10), 2001, pp. 3058-3065
Authors:
Deeg, HJ
Beckham, C
Loken, MR
Bryant, E
Lesnikova, M
Shulman, HM
Gooley, T
Citation: Hj. Deeg et al., Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome, LEUK LYMPH, 37(3-4), 2000, pp. 405
Authors:
Cooper, LJN
Shannon, KM
Loken, MR
Weaver, M
Stephens, K
Sievers, EL
Citation: Ljn. Cooper et al., Evidence that juvenile myelomonocytic leukemia can arise from a pluripotential stem cell, BLOOD, 96(6), 2000, pp. 2310-2313
Authors:
Shulman, HM
Wells, D
Gooley, T
Myerson, D
Bryant, E
Loken, MR
Citation: Hm. Shulman et al., The biologic significance of rare peripheral blasts after hematopoietic cell transplantation is predicted by multidimensional flow cytometry, AM J CLIN P, 112(4), 1999, pp. 513-523
Occult B cell malignancies can be detected by three-color flow cytometry in patients with cytopenias
Authors:
Wells, DA
Hall, MC
Shulman, HM
Loken, MR
Citation: Da. Wells et al., Occult B cell malignancies can be detected by three-color flow cytometry in patients with cytopenias, LEUKEMIA, 12(12), 1998, pp. 2015-2023
Authors:
Wells, DA
Loken, MR
Citation: Da. Wells et Mr. Loken, More on hematogones, LAB MED, 29(12), 1998, pp. 728-728
Risultati:
1-7
|